Cuban annual raw sugar production will fall below 200,000 metric tons in 2025 for the first time since the 19th century, potentially leaving rum makers short of a key ingredient, according to recent official reports and an industry source.

Novo Nordisk looks to harness Septerna’s broader GPCR drug pathways, which include GLP-1, for obesity and diabetes treatments.

New research has shown that Ozempic can cause taste changes in people taking it, even going so far as to make some hate the taste of meat.

One weight loss injection has been branded more effective than another, after scientists carry out the first ever head-to-head trial of Mounjaro and Wegovy.

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies. Compare side effects here.

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food cravings and is also available for people with a high BMI.

A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been peer-reviewed. Females in the study were twice as likely to lose hair as males.